Results from the Children's Oncology Group phase III trial of a monoclonal antibody against the insulin-like growth factor-1 receptor in patients with newly diagnosed metastatic Ewing sarcoma
Por:
Carcaboso AM
Publicada:
1 oct 2023
Ahead of Print:
1 oct 2023
Categoría:
Pediatrics, perinatology and child health
Resumen:
Filiaciones:
Carcaboso AM:
Pediatric Cancer Program, Institut de Recerca Sant Joan de Deu, Barcelona, Spain
SJD Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu, Barcelona, Spain
Hosp St Joan Deu, SJD Pediat Canc Ctr Barcelona, Barcelona, Spain
Inst Recerca St Joan Deu, Pediat Canc Program, Barcelona, Spain
Hosp St Joan Deu, SJD Pediat Canc Ctr Barcelona, St Rosa 39-57, Esplugas
de Llobregat 08950, Barcelona, Spain
Green Published, gold
|